QHA
- Product code
- QHA
- Device name
- X-Ray Angiographic Imaging Based Coronary Vascular Simulation Software Device
- Device class
- Class 2
- 21 CFR
- 21 CFR 892.1600
- Medical specialty
- Radiology
- Marketing pathway
- 510(K)
- 510(k) clearances (last 3 years)
- 3
- Summaries archived here
- 3 (direct download)
- 510(k) clearances (all years, FDA)
- 7 (all years; only the last 3 years are listed here)
FDA classification definition
X-ray angiographic imaging based coronary vascular simulation software device is a prescription device that provides an image analysis tool to assess blood flow in the coronary vascular system using X-ray angiographic imaging data. X-ray angiographic imaging based coronary vascular simulation software device solves algorithms and yields simulation-based metrics for certain cardiology applications. X-ray angiographic imaging based coronary vascular simulation software device cannot be used alone for clinical decision making and clinical management, and is a tool intended to generate results for use and review by a qualified clinician.
510(k) clearances, last 3 years (3)
| Number | Decision date | Applicant | Device name | Summary |
|---|---|---|---|---|
| K251355 | 2025-10-17 | Spectrawave, Inc. | X1-FFR | |
| K243769 | 2025-04-04 | Qfr Solutions BV | QFR (3.0) | |
| K232147 | 2024-04-09 | Pie Medical Imaging BV | CAAS Workstation |
Official FDA classification page: QHA
Classification and pathway per current FDA publications. Data from openFDA (CC0).